| Literature DB >> 35705583 |
Mohan Lal1, Twahira Begum2,3, Roktim Gogoi2,3, Neelav Sarma2,3, Sunita Munda2,3, Sudin Kumar Pandey2,3, Joyashree Baruah2, Raghu Tamang2, Samarjit Saikia2.
Abstract
Anethole, a widely used industrial flavoring agent is majorly sourced from anise and star anise. The present study is aimed to the in-depth pharmacological analysis i.e. anti-diabetic, skin whitening, neurodegenerative disorder inhibitory activities of anethole-rich Clausena heptaphylla leaf essential oil (ARCHEO) (88.59%) as revealed by the Gas Chromatography/Mass Spectrometry (GC/MS) analysis and further confirmed by proton nuclear magnetic resonance 1H-NMR as well as to compare with standard compound anethole. ARCHEO (ABTS EC50 6.97 ± 0.004 µg/mL; Protease assay 4.51 ± 0.004 µg/mL) outperformed the standard compound anethole (ABTS EC50 9.48 ± 0.048 µg/mL; Protease assay EC50 22.64 ± 0.016 µg/mL) in antioxidant and anti-inflammatory experiments. ARCHEO was also shown to be more effective than the reference compound anethole in terms of anti-diabetic activity (EC50 22.35 ± 0.121 µg/mL), tyrosinase inhibitory activity (EC50 16.45 ± 0.012 µg/mL), and anti-cholinesterase activity (EC50 22.32 ± 0.016 µg/mL). However, ARCHEO exhibited lower antimicrobial activity towards all the tested microbes compared to standard compound anethole and as for the MIC, ARCHEO was effective only towards Salmonella typhimurium (60 µg/mL), Streptococcus mutans (20 µg/mL), and Aspergillus fumigatus (75 µg/mL). ARCHEO (11.11%) and anethole (12.33%) showed no genotoxic effect based on Allium cepa assay mitotic index value. Thus, ARCHEO could be a commercially viable and widely available cheaper source of anethole, which has buoyant demand in the field of food flavoring, fragrance, and pharmaceutical industries.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35705583 PMCID: PMC9200763 DOI: 10.1038/s41598-022-13511-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
GC/MS analysis of essential oil of anethole-rich C. heptaphylla essential oil (ARCHEO).
| Sl. no. | Name of the compound | RT | Area % | KI* | KI** | Identification method |
|---|---|---|---|---|---|---|
| 1 | Estragole | 10.68 | 5.36 | 1196 | 1198 | 1,2,3 |
| 2 | 11.65 | 0.80 | 1254 | 1256 | 1,2,3 | |
| 3 | 12.24 | 88.59 | 1284 | 1285 | 1,2,3 | |
| 4 | 13.88 | 0.07 | 1384 | 1385 | 1,2 | |
| 5 | Caryophyllene | 14.57 | 0.04 | 1419 | 1420 | 1,2,3 |
| 6 | 15.18 | 0.46 | 1463 | 1465 | 1,2,3 | |
| 7 | Benzene, 1,2-dimethoxy-4-(1-propenyl Isoeugenolmethyl ether | 15.64 | 0.10 | 1492 | 1492 | 1,2 |
| 8 | Bicyclogermacrene | 15.77 | 0.30 | 1495 | 1496 | 1,2 |
| 9 | Cubebol | 16.13 | 0.03 | 1515 | 1518 | 1,2 |
| 10 | Ethyl p-methoxycinnamate | 19.39 | 4.03 | 1773 | 1774 | 1,2,3 |
Total = 100%, Identified compounds = 99.78%, Unidentified compounds = 0.22% Ether (Sl No. 1–3, 7) = 94.85% Acetophenones (Sl No. 4) = 0.07% Sesquiterpene hydrocarbons (Sl No. 5, 8) = 0.34% Oxygenated sesquiterpene (Sl No. 9) = 0.03% Cinnamic acid esters (Sl No. 6, 10) = 4.49% | ||||||
KI* Kovats Index Literature[15], KI** Kovats Index Experimental, 1. Comparison of retention indices with literatures, 2. Comparison of the mass spectra with the mass libraries, 3. Comparing retention time with standards injected with same GC condition.
Figure 1(a) Chromatogram of GC/MS analysis of ARCHEO; (b) NMR spectra of ARCHEO; (c) NMR spectra of the pure standard compound anethole.
50% Inhibition concentrations (IC50) determination values for pharmacological activities of ARCHEO and standards using MS-EXCEL software.
| Essential oil/standard | DPPH scavenging (µg/mL) | ABTS scavenging (µg/mL) | Metal chelating (µg/mL) | Protein denaturation (µg/mL) | Protease inhibitory (µg/mL) | Tyrosinase inhibitory (µg/mL) | Acetylcholinesterase inhibitory (µg/mL) | α-Amylase inhibitory (µg/mL) |
|---|---|---|---|---|---|---|---|---|
| ARCHEO | 10.01 ± 0.012 | 7.14 ± 0.086 | 21.24 ± 0.021 | 21.19 ± 0.006 | 5.05 ± 0.003 | 17.52 ± 0.012 | 22.85 ± 0.024 | 22.80 ± 0.057 |
| Anethole standard | 10.94 ± 0.026 | 9.26 ± 0.002 | 31.02 ± 0.018 | 19.26 ± 0.028 | 20.84 ± 0.042 | 15.97 ± 0.022 | 33.81 ± 0.016 | 22.16 ± 0.12 |
| Ascorbic acid | 17.27 ± 0.004 | 17.61 ± 0.012 | ND | ND | ND | ND | ND | ND |
| EDTA | ND | ND | 29.92 ± 0.002 | ND | ND | ND | ND | ND |
| Sodium diclofenac | ND | ND | ND | 25.35 ± 0.042 | 24.54 ± 0.011 | ND | ND | ND |
| Kojic acid | ND | ND | ND | ND | ND | 21.12 ± 0.018 | ND | ND |
| Galanthamine hydrobromide | ND | ND | ND | ND | ND | ND | 27.62 ± 0.002 | ND |
| Acarbose | ND | ND | ND | ND | ND | ND | ND | 23.76 ± 0.014 |
ARCHEO anethole rich C. heptaphylla essential oil, ND not determined.
50% Effective concentrations (EC50) determination values for pharmacological activities of ARCHEO and standards using XLSTAT software.
| Essential oil/standard | DPPH scavenging (µg/mL) | ABTS scavenging (µg/mL) | Metal chelating (µg/mL) | Protein denaturation (µg/mL) | Protease inhibitory (µg/mL) | Tyrosinase inhibitory (µg/mL) | Acetylcholinesterase inhibitory (µg/mL) | α-Amylase inhibitory (µg/mL) |
|---|---|---|---|---|---|---|---|---|
| ARCHEO | 8.64 ± 0.12 | 6.97 ± 0.004 | 16.91 ± 0.084 | 24.37 ± 0.042 | 4.51 ± 0.004 | 16.45 ± 0.012 | 22.32 ± 0.016 | 22.35 ± 0.121 |
| Anethole standard | 8.69 ± 0.058 | 9.48 ± 0.048 | 29.54 ± 0.032 | 19.63 ± 0.002 | 22.64 ± 0.016 | 15.46 ± 0.004 | 30.90 ± 0.021 | 21.75 ± 0.008 |
| Ascorbic acid | 17.55 ± 0.056 | 19.54 ± 0.121 | ND | ND | ND | ND | ND | ND |
| EDTA | ND | ND | 29.33 ± 0.064 | ND | ND | ND | ND | ND |
| Sodium diclofenac | ND | ND | ND | 27.38 ± 0.012 | 25.42 ± 0.002 | ND | ND | ND |
| Kojic acid | ND | ND | ND | ND | ND | 19.03 ± 0.082 | ND | ND |
| Galanthamine hydrobromide | ND | ND | ND | ND | ND | ND | 26.56 ± 0.016 | ND |
| Acarbose | ND | ND | ND | ND | ND | ND | ND | 23.52 ± 0.056 |
ARCHEO anethole rich C. heptaphylla essential oil, ND not determined.
50% Inhibition concentrations (IC50) determination values for pharmacological activities of ARCHEO, and standards using Graph Pad Prism software.
| Eeesential oil/ Standard | DPPH scavenging (µg/mL) | ABTS scavenging (µg/mL) | Metal chelating (µg/mL) | Protein denaturation (µg/mL) | Protease inhibitory (µg/mL) | Tyrosinase inhibitory (µg/mL) | Acetylcholinesterase inhibitory (µg/mL) | α-Amylase inhibitory (µg/mL) |
|---|---|---|---|---|---|---|---|---|
| ARCHEO | 0.42 ± 0.056 | 6.27 ± 0.024 | 5.94 ± 0.014 | 207.30 ± 0.001 | 0.28 ± 0.014 | 48.91 ± 0.086 | 9.29 ± 0.036 | 19.57 ± 0.014 |
| Anethole standard | 0.58 ± 0.048 | 34.9 ± 0.004 | 12.15 ± 0.032 | 204.80 ± 0.042 | 0.36 ± 0.012 | 22.88 ± 0.008 | 21.42 ± 0.082 | 13.08 ± 0.016 |
| Ascorbic acid | 0.60 ± 0.121 | 39.31 ± 0.84 | ND | ND | ND | ND | ND | ND |
| EDTA | ND | ND | 12.11 ± 0.002 | ND | ND | ND | ND | ND |
| Sodium diclofenac | ND | ND | ND | 216.80 ± 0.016 | 0.42 ± 0.002 | ND | ND | ND |
| Kojic acid | ND | ND | ND | ND | ND | 51.56 ± 0.001 | ND | ND |
| Galanthamine hydrobromide | ND | ND | ND | ND | ND | ND | 11.61 ± 0.016 | ND |
| Acarbose | ND | ND | ND | ND | ND | ND | ND | 20.35 ± 0.002 |
ARCHEO anethole rich C. heptaphylla essential oil, ND not determined.
Figure 2Reducing power activities of ARCHEO, anethole and ascorbic acid with standard error bars.
Root lengths of Allium cepa after treatment of ARCHEO, anethole (standard) and EMS.
| Concentrations (μL/mL) | Before treatment (in cm) ± SD | After treatment (in cm) ± SD | Root length on 72 h (in cm) ± SD |
|---|---|---|---|
| Distilled water | 7.54 ± 0.010 | 8.42 ± 0.012 | 0.88 ± 0.010 |
| EMS | 7.24 ± 0.014 | 7.31 ± 0.013 | 0.07 ± 0.012 |
| ARCHEO | 7.56 ± 0.013 | 8.17 ± 0.011 | 0.61 ± 0.011 |
| Anethole standard | 7.71 ± 0.016 | 8.36 ± 0.009 | 0.65 ± 0.017 |
ARCHEO anethole rich C. heptaphylla essential oil, EMS Ethyl methanesulphonate.
Zone of inhibitons and minimal inhibitory concentration (MIC) for ARCHEO and anethole standard against different bacterial and fungal strains.
| Microorganisms | 50 (μg/mL) mm | 100 (μg/mL) mm | 250 (μg/mL) mm | 500 (μg/mL) mm | ARCHEO MIC (μg/mL) | AS MIC (μg/mL) | (ciprofloxacin/fluconazole) (10 µg/disc) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARCHEO | AS | ARCH | AS | ARCH | AS | ARCH | AS | ||||
| – | – | – | 8 | – | 10 | 11 | 14 | NA | 95 | 19 ± 0.017 | |
| – | – | 7 | 8 | 9 | 11 | 11 | 13 | NA | 90 | 16 ± 0.015 | |
| – | – | – | – | 12 | 13 | 14 | 16 | NA | NA | 15 ± 0.013 | |
| – | 8 | 10 | 12 | 11 | 15 | 14 | 17 | 60 | 45 | 21 ± 0.015 | |
| 11 | 12 | 14 | 16 | 17 | 18 | 20 | 23 | 20 | 15 | 7 ± 0.015 | |
| – | – | 8 | 12 | 10 | 14 | 13 | 18 | 75 | 65 | 16 ± 0.011 | |
| – | – | – | – | – | 16 | 18 | 21 | NA | NA | 12 ± 0.013 | |
| – | – | – | – | – | – | 12 | 16 | NA | NA | 14 ± 0.016 | |
| – | – | – | – | 8 | 15 | 11 | 19 | NA | NA | 20 ± 0.014 | |
ARCHEO anethole rich C. heptaphylla essential oil, AS anethole standard, NA not applicable.
Mitotic index and different stages of dividing cells in root tips of Allium cepa treated with ARCHEO, anethole (standard) and EMS.
| Concentration (μL/mL) | Mitotic index (%) | Prophase (%) | Metaphase (%) | Anaphase (%) | Telophase (%) |
|---|---|---|---|---|---|
| Distilled water | 14.73 | 48.65 | 33.27 | 12.42 | 5.66 |
| EMS | 1.96 | 86.73 | 13.27 | 0 | 0 |
| ARCHEO | 11.11 | 64.44 | 20.00 | 6.67 | 8.89 |
| Anethole standard | 12.33 | 59.46 | 18.92 | 13.51 | 8.10 |
ARCHEO anethole rich C. heptaphylla essential oil, EMS ethyl methanesulphonate.
Chromosomal aberration test for ARCHEO, anethole (standard) and EMS.
| Compound | Concentration | Time | Bridges | Stickiness | Clumped | Multipolarity | Breakage | Total abberations |
|---|---|---|---|---|---|---|---|---|
| Distilled water | 01.00 µL/mL | 72 h | 8 | 9 | 2 | 5 | 6 | 06.00% |
| ARCHEO | 14 | 11 | 6 | 10 | 8 | 09.80% | ||
| Anethole standard | 12 | 4 | 7 | 3 | 9 | 07.00% | ||
| EMS | 30 | 28 | 14 | 21 | 15 | 21.60% |
ARCHEO anethole rich C. heptaphylla essential oil, EMS ethyl methanesulphonate.
Figure 3Chromosome aberrations (Allium cepa assay, genotoxicity); (A) Chromosome break, (B) Chromosome bridge, (C) Chromosome clump and (D) Stickiness chromosome.